Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

0Q1N

Pfizer (0Q1N)

Pfizer Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0Q1N
日付受信時刻ニュースソース見出しコード企業名
2024/05/0121 : 42Alliance NewsAlliance NewsTOP NEWS: Pfizer profit declines on lower Covid-related salesLSE:0Q1NPfizer Inc
2024/04/2314 : 27Alliance NewsAlliance NewsModerna, Pfizer/BioNTech set for UK court clash over Covid jab patentsLSE:0Q1NPfizer Inc
2024/04/1002 : 41Alliance NewsAlliance NewsPfizer RSV treatment meets targets in trial of adults under age 60LSE:0Q1NPfizer Inc
2024/03/2201 : 29Alliance NewsAlliance NewsTOP NEWS: Haleon buys back shares worth GBP315 million from PfizerLSE:0Q1NPfizer Inc
2024/03/1919 : 17Alliance NewsAlliance NewsHaleon to buy back shares from Pfizer for GBP315 millionLSE:0Q1NPfizer Inc
2024/03/1817 : 47Alliance NewsAlliance NewsTOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in HaleonLSE:0Q1NPfizer Inc
2024/03/1401 : 28Alliance NewsAlliance NewsIN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcalLSE:0Q1NPfizer Inc
2024/03/0203 : 27Alliance NewsAlliance NewsPfizer targets eight blockbuster drugs by 2030 in new oncology planLSE:0Q1NPfizer Inc
2024/01/3021 : 56Alliance NewsAlliance NewsTOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boostLSE:0Q1NPfizer Inc
2024/01/2917 : 26Alliance NewsAlliance NewsAstellas and Pfizer's Padcev validated by EMA to treat bladder cancerLSE:0Q1NPfizer Inc
2024/01/0922 : 49Alliance NewsAlliance NewsPfizer's licence application accepted for priority review of TivdakLSE:0Q1NPfizer Inc
2024/01/0903 : 09Alliance NewsAlliance NewsIN BRIEF: Pfizer wins European approval for prostate cancer treatmentLSE:0Q1NPfizer Inc
2023/12/1923 : 13Alliance NewsAlliance NewsTOP NEWS: Pfizer sues Poland and Hungary over Covid debtsLSE:0Q1NPfizer Inc
2023/12/1820 : 04Alliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0Q1NPfizer Inc
2023/12/1401 : 11Alliance NewsAlliance NewsTOP NEWS: Pfizer shares slide as 2024 revenue outlook underwhelmsLSE:0Q1NPfizer Inc
2023/12/1221 : 35Alliance NewsAlliance NewsPfizer's USD43 billion Seagen buy given regulatory nodLSE:0Q1NPfizer Inc
2023/12/1118 : 08Alliance NewsAlliance NewsPfizer's Elrexfio wins EU approval for form of multiple myelomaLSE:0Q1NPfizer Inc
2023/12/0201 : 54Alliance NewsAlliance NewsTOP NEWS: Pfizer rethinks weight loss pill after high side effect rateLSE:0Q1NPfizer Inc
2023/11/1514 : 55Alliance NewsAlliance NewsPfizer to axe 500 jobs at Kent site amid cost-cutting programmeLSE:0Q1NPfizer Inc
2023/10/3120 : 45Alliance NewsAlliance NewsTOP NEWS: Pfizer outlook downbeat as swings to loss in third quarterLSE:0Q1NPfizer Inc
2023/10/2105 : 25Alliance NewsAlliance NewsUS FDA approves Pfizer's Penbraya for meningococcal diseaseLSE:0Q1NPfizer Inc
2023/10/2000 : 37Alliance NewsAlliance NewsEU clears Pfizer's USD43 billion takeover of biotech firm SeagenLSE:0Q1NPfizer Inc
2023/10/1502 : 03Alliance NewsAlliance NewsPfizer cuts earnings outlook on lower Covid-19 drug salesLSE:0Q1NPfizer Inc
2023/10/0601 : 20Alliance NewsAlliance NewsTOP NEWS: GSK plans to sell further 270 million shares in HaleonLSE:0Q1NPfizer Inc
2023/09/2016 : 44Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolioLSE:0Q1NPfizer Inc
2023/09/1216 : 04Alliance NewsAlliance NewsUS FDA approves updated Covid vaccines from Pfizer and ModernaLSE:0Q1NPfizer Inc
2023/08/2502 : 36Alliance NewsAlliance NewsEuropean Commission inks marketing authorisation for Pfizer's AbrysvoLSE:0Q1NPfizer Inc
2023/08/2322 : 41Alliance NewsAlliance NewsAstellas says US FDA grants priority review for Xtandi drugLSE:0Q1NPfizer Inc
2023/08/2213 : 45Alliance NewsAlliance NewsUS approves Pfizer's maternal vaccine to prevent RSV in infantsLSE:0Q1NPfizer Inc
2023/08/0304 : 45Alliance NewsAlliance NewsTOP NEWS: GSK sues Pfizer over patent infingements for RSV vaccineLSE:0Q1NPfizer Inc
 Showing the most relevant articles for your search:LSE:0Q1N